Lipid profile changes in patients with acute leukemia after pathogenetic therapy

Aim. To study changes in lipid profile in patients with acute leukemia who received pathogenetic therapy.Material and methods. The study included 13 patients diagnosed with acute leukemia who underwent pathogenetic therapy, including multiagent chemotherapy and allogeneic hematopoietic stem cell tra...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. A. Praskurnichy, V. О. Dzidzaria, Yu. S. Kitaeva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2025-05-01
Series:	Российский кардиологический журнал
Subjects:	acute leukemia dyslipidemia multiagent chemotherapy allogeneic hematopoietic stem cell transplantation
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5910
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of risk factors for relapse after allogeneic hematopoietic stem cell transplantation in acute leukemia
by: Jiawen Wang, et al.
Published: (2025-12-01)

Posttransplant Erythrocytosis after Allogenic Stem Cell Transplant for Acute Myeloid Leukemia: A Case Report and Review of Literature
by: Sherry S. Abraham, et al.

Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
by: Koichi Hirabayashi, et al.
Published: (2017-02-01)

Advancing the pathway to allogeneic hematopoietic stem cell transplantation through a physician–nurse coordinator system in patients with acute leukemia
by: Chidapa Auepisit, et al.
Published: (2025-07-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias with Hyperdiploid Karyotype
by: TL Gindina, et al.
Published: (2016-10-01)

THE EFFICACY OF HIGH-DOSE CONSOLIDATION AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN FIRST REMISSION OF ACUTE MYELOID LEUKEMIA
by: I. A. Samorodova, et al.
Published: (2018-05-01)

Comparison of the efficacy of chemotherapy and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first remission in adults
by: S. N. Bondarenko, et al.
Published: (2015-09-01)

Clinical Value of miR-3151 Overexpression in Synergistic Interaction with BAALC Host Gene in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
by: AI Shakirova, et al.
Published: (2019-05-01)

Blood Serum from Patients with Acute Leukemia Inhibits the Growth of Bone Marrow Multipotent Mesenchymal Stromal Cells
by: Nataliya Petinati, et al.
Published: (2025-05-01)

Place of Allogeneic Hematopoietic Stem Cell Transplantation in the First Complete Remission in Ph-positive Acute Lymphoblastic Leukemia in Adults
by: K. S. Afanaseva, et al.
Published: (2023-12-01)

Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation
by: VN Ovechkina, et al.
Published: (2017-01-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Ruxolitinib and decitabine plus a busulfan–cyclophosphamide conditioning regimen for relapse prophylaxis in patients with high-risk acute myeloid leukemia or myelodysplastic syndromes
by: Yujun Wei, et al.
Published: (2025-08-01)

Cytogenetic Abnormalities and Their Impact on Acute Myeloid Leukemia Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single‐Center Retrospective Study
by: Amir Abbas Rashidi, et al.
Published: (2025-06-01)

Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
by: A. S. Frolova, et al.
Published: (2022-11-01)

The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: VN Ovechkina, et al.
Published: (2017-07-01)

Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia
by: E. V. Semenova, et al.
Published: (2014-07-01)

Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trialResearch in context
by: Qifa Liu, et al.
Published: (2025-08-01)

Acute symptomatic seizures during haematopoietic stem cell transplantation
by: Ya. B. Skiba, et al.
Published: (2021-04-01)

Efficacy and safety of mitoxantrone hydrochloride liposome-containing regimens in treating refractory/relapsed acute myeloid leukemia
by: Ni Lu, et al.
Published: (2025-05-01)

Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation
by: Yasutaka Sadaga, et al.
Published: (2025-12-01)

First experience of total body irradiation in conditioning regimes for allogenic hematopoietic stem cells transplantation in children with acute lymphoblastic leukemia in Saint Petersburg
by: Yu. V. Dinikina, et al.
Published: (2022-11-01)

Outcomes of Allogeneic Stem Cell Transplant in Chronic Myeloid Leukemia-Blast Phase: A Single-Center Experience from South India
by: Thejeswar Nakka, et al.
Published: (2025-06-01)

Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry
by: T. N. Tolstykh, et al.
Published: (2024-09-01)

Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias: Prognostic Significance of Complex Karyotype Including del(5q), –7, del(7q) Abnormalities
by: TL Gindina, et al.
Published: (2016-07-01)

A novel prognostic scoring system for AML patients undergoing allogeneic hematopoietic stem cell transplantation with real world validation
by: Qing Ya Wang, et al.
Published: (2025-07-01)

Post-stem cell transplant maintenance for pediatric acute leukemias: insights from a Brazilian institution with a Latin American perspective
by: Carla Nolasco Monteiro Breviglieri, et al.
Published: (2025-03-01)

ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
by: saveria capria, et al.
Published: (2012-01-01)

ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
by: saveria capria, et al.
Published: (2012-11-01)

Comparative analysis of allogeneic hematopoietic cell transplantation in patients with therapy-related and de novo acute promyelocytic leukemia A retrospective study
by: Satoshi Yamasaki, et al.
Published: (2025-03-01)

How to reduce the risk of primary engraftment failure after haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia?
by: D. K. Zhogolev, et al.
Published: (2025-03-01)

Congenital Acute Myeloid Leukemia (AML): A Case Report
by: Alsharidah S, et al.
Published: (2025-05-01)

ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Federico Lussana, et al.
Published: (2014-10-01)

Efficacy and safety of blinatumomab for the treatment of patients relapsing after allogeneic hematopoietic cell transplantation: a systemic review and meta-analysis
by: Huai-Peng Guo, et al.
Published: (2024-12-01)

Clinical features and outcomes of patients with acute myeloid leukemia: the single-center experience of 668 patients in China
by: Jie Ding, et al.
Published: (2024-12-01)

Comparison of autologous hematopoietic cell transplantation, matched sibling donor hematopoietic cell transplantation, and chemotherapy in patients with favorable- and intermediate-risk acute myeloid leukemia
by: Mingyang Wang, et al.
Published: (2025-01-01)

Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Analysis on Behalf of the Polish Adult Leukemia Group
by: Ugo Giordano, et al.
Published: (2025-01-01)

Case report: TP53 c.848G>A germline mutation as a possible screening target at initial diagnosis for acute lymphoblastic leukemia
by: Fang Hua, et al.
Published: (2024-12-01)

Clinical outcomes of allogeneic hematopoietic stem cell transplant with different stem cell sources in infant acute myeloid leukemia
by: Yuyang Wang, et al.
Published: (2025-07-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)